September 30, 2025 Deadline: Contact The Gross Law Firm to Join Class Action Suit Against NVO

Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of Novo Nordisk A/S regarding a class action lawsuit due to misleading statements about the company's growth potential and subsequent stock price decline [1][3]. Group 1: Allegations and Impact - The allegations state that Novo Nordisk provided overly positive statements while concealing material adverse facts about its growth potential, particularly regarding the GLP-1 market and competition [3]. - On July 29, 2025, Novo Nordisk lowered its sales and profit outlook, attributing this to lower growth expectations for its products Wegovy and Ozempic, which led to a significant stock price drop from $69.00 to $53.94, a decline of approximately 21.83% in one day [3]. Group 2: Class Action Details - The class period for the lawsuit is from May 7, 2025, to July 28, 2025, and shareholders are encouraged to register for participation [3][4]. - The deadline for shareholders to seek lead plaintiff status is September 30, 2025, and there is no cost to participate in the case [4]. Group 3: Firm's Commitment - The Gross Law Firm aims to protect investors' rights and seeks recovery for those who suffered losses due to misleading statements or omissions by companies [5].